Clinical Trials Directory

Trials / Completed

CompletedNCT02025270

MSCs For Treatment of Azoospermic Patients

Using of Bone Marrow Derived Mesenchymal Stem Cells For Treatment of Azoospermic Patients

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Al-Azhar University · Academic / Other
Sex
Male
Age
20 Years – 50 Years
Healthy volunteers
Not accepted

Summary

In this study, we performed autologous BMDMSC transplantation to the testis of Azoospermic patients in a trial to enhance and activate the spermatogonial stem cells of the testis and aiming to produce motile sperm.

Detailed description

Bone marrow aspirated and stem cells were isolated, cultured and characterized using flow cytometer. Stem cells prepared according to GMP regulations then injected into rete testis using special syringe. Patients follow up will carried out for a year , three month interval. FSH, testosterone, testicular size as well as sexual potency will assessed every three months.

Conditions

Interventions

TypeNameDescription
BIOLOGICALStem Cells60 ml of bone marrow will aspirated and used for stem cells isolation. Then stem cells will cultured using autologous serum, characterized and prepared using GMP rules and finally injected into rete testis.

Timeline

Start date
2012-10-15
Primary completion
2016-10-15
Completion
2022-12-20
First posted
2014-01-01
Last updated
2023-03-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02025270. Inclusion in this directory is not an endorsement.

MSCs For Treatment of Azoospermic Patients (NCT02025270) · Clinical Trials Directory